Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group.

MLA

Locasciulli, Anna, et al. “Treatment of Aplastic Anaemia with Granulocyte-Colony Stimulating Factor and Risk of Malignancy. Italian Aplastic Anaemia Study Group.” Lancet, vol. 357, no. 9249, Jan. 2001, pp. 43–44. EBSCOhost, https://doi.org/10.1016/S0140-6736(00)03574-1.

APA

Locasciulli, A., Arcese, W., Locatelli, F., Di Bona, E., Bacigalupo, A., Locasciulli, A., Arcese, W., Locatelli, F., Di Bona, E., Bacigalupo, A., & Italian Aplastic Anaemia Study Group. (2001). Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet, 357(9249), 43–44. https://doi.org/10.1016/S0140-6736(00)03574-1

Chicago

Locasciulli, Anna, William Arcese, Franco Locatelli, Eros Di Bona, Andrea Bacigalupo, A Locasciulli, W Arcese, et al. 2001. “Treatment of Aplastic Anaemia with Granulocyte-Colony Stimulating Factor and Risk of Malignancy. Italian Aplastic Anaemia Study Group.” Lancet 357 (9249): 43–44. doi:10.1016/S0140-6736(00)03574-1.